Loading
Latest filing published 05 Aug 2026 for Camp4 Therapeutics Corp, €9,372.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kelly Gold discloses dealings in Camp4 Therapeutics Corp to SEC (Form 4). In total, 2 filings cover trades dated from 11 September 2025 to 3 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €18k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
The latest filing, published on 5 August 2026, reports an open-market purchase of €9,372 in Camp4 Therapeutics Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 1 declaration